RADNET INC (RDNT) Stock Fundamental Analysis
USA - NASDAQ:RDNT - US7504911022 - Common Stock
73.81 USD
+2.09 (+2.91%)
73.81 USD
0 (0%)
We assign a fundamental rating of 4 out of 10 to RDNT. RDNT was compared to 100 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of RDNT get a neutral evaluation. Nothing too spectacular is happening here. RDNT is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year RDNT was profitable.
In the past year RDNT had a positive cash flow from operations.
Of the past 5 years RDNT 4 years were profitable.
RDNT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
RDNT has a Return On Assets of -0.42%. This is comparable to the rest of the industry: RDNT outperforms 46.00% of its industry peers.
RDNT has a Return On Equity (-1.60%) which is comparable to the rest of the industry.
With a Return On Invested Capital value of 2.21%, RDNT perfoms like the industry average, outperforming 44.00% of the companies in the same industry.
RDNT had an Average Return On Invested Capital over the past 3 years of 2.96%. This is significantly below the industry average of 9.33%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.42% | ||
| ROE | -1.6% | ||
| ROIC | 2.21% |
ROA(3y)0.21%
ROA(5y)0.2%
ROE(3y)1.34%
ROE(5y)1.17%
ROIC(3y)2.96%
ROIC(5y)2.94%
1.3 Margins
In the last couple of years the Profit Margin of RDNT has declined.
RDNT has a Operating Margin of 4.17%. This is comparable to the rest of the industry: RDNT outperforms 57.00% of its industry peers.
In the last couple of years the Operating Margin of RDNT has remained more or less at the same level.
RDNT has a Gross Margin of 22.67%. This is comparable to the rest of the industry: RDNT outperforms 46.00% of its industry peers.
RDNT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.17% | ||
| PM (TTM) | N/A | ||
| GM | 22.67% |
OM growth 3Y-5.61%
OM growth 5Y-1.02%
PM growth 3Y-56.68%
PM growth 5Y-34.67%
GM growth 3Y0.24%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
RDNT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, RDNT has about the same amount of shares outstanding.
The number of shares outstanding for RDNT has been increased compared to 5 years ago.
RDNT has a worse debt/assets ratio than last year.
2.2 Solvency
RDNT has an Altman-Z score of 2.08. This is not the best score and indicates that RDNT is in the grey zone with still only limited risk for bankruptcy at the moment.
RDNT has a Altman-Z score (2.08) which is comparable to the rest of the industry.
RDNT has a debt to FCF ratio of 14.51. This is a negative value and a sign of low solvency as RDNT would need 14.51 years to pay back of all of its debts.
RDNT has a Debt to FCF ratio of 14.51. This is comparable to the rest of the industry: RDNT outperforms 42.00% of its industry peers.
RDNT has a Debt/Equity ratio of 1.16. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.16, RDNT is doing worse than 65.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.16 | ||
| Debt/FCF | 14.51 | ||
| Altman-Z | 2.08 |
ROIC/WACC0.25
WACC9%
2.3 Liquidity
A Current Ratio of 2.00 indicates that RDNT has no problem at all paying its short term obligations.
RDNT has a Current ratio of 2.00. This is in the better half of the industry: RDNT outperforms 74.00% of its industry peers.
A Quick Ratio of 2.00 indicates that RDNT has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.00, RDNT is in the better half of the industry, outperforming 77.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2 | ||
| Quick Ratio | 2 |
3. Growth
3.1 Past
The earnings per share for RDNT have decreased strongly by -36.84% in the last year.
Measured over the past years, RDNT shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.79% on average per year.
Looking at the last year, RDNT shows a quite strong growth in Revenue. The Revenue has grown by 11.32% in the last year.
Measured over the past years, RDNT shows a quite strong growth in Revenue. The Revenue has been growing by 9.65% on average per year.
EPS 1Y (TTM)-36.84%
EPS 3Y-1.04%
EPS 5Y16.79%
EPS Q2Q%93.75%
Revenue 1Y (TTM)11.32%
Revenue growth 3Y11.64%
Revenue growth 5Y9.65%
Sales Q2Q%8.38%
3.2 Future
Based on estimates for the next years, RDNT will show a very strong growth in Earnings Per Share. The EPS will grow by 26.32% on average per year.
Based on estimates for the next years, RDNT will show a small growth in Revenue. The Revenue will grow by 7.97% on average per year.
EPS Next Y-39.08%
EPS Next 2Y16.22%
EPS Next 3Y26.32%
EPS Next 5YN/A
Revenue Next Year8.63%
Revenue Next 2Y8.59%
Revenue Next 3Y7.97%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 205.03, which means the current valuation is very expensive for RDNT.
RDNT's Price/Earnings ratio is in line with the industry average.
RDNT is valuated expensively when we compare the Price/Earnings ratio to 27.49, which is the current average of the S&P500 Index.
RDNT is valuated quite expensively with a Price/Forward Earnings ratio of 86.74.
RDNT's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of RDNT to the average of the S&P500 Index (22.99), we can say RDNT is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 205.03 | ||
| Fwd PE | 86.74 |
4.2 Price Multiples
RDNT's Enterprise Value to EBITDA ratio is in line with the industry average.
RDNT's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 74.69 | ||
| EV/EBITDA | 30.96 |
4.3 Compensation for Growth
A more expensive valuation may be justified as RDNT's earnings are expected to grow with 26.32% in the coming years.
PEG (NY)N/A
PEG (5Y)12.21
EPS Next 2Y16.22%
EPS Next 3Y26.32%
5. Dividend
5.1 Amount
No dividends for RDNT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
73.81
+2.09 (+2.91%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners93.61%
Inst Owner Change0%
Ins Owners12.96%
Ins Owner Change-4.73%
Market Cap5.68B
Analysts86.15
Price Target80.87 (9.57%)
Short Float %9.62%
Short Ratio8.08
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-33.8%
Min EPS beat(2)-161.6%
Max EPS beat(2)93.99%
EPS beat(4)3
Avg EPS beat(4)-10.19%
Min EPS beat(4)-161.6%
Max EPS beat(4)93.99%
EPS beat(8)6
Avg EPS beat(8)171.54%
EPS beat(12)7
Avg EPS beat(12)120.14%
EPS beat(16)9
Avg EPS beat(16)-188.91%
Revenue beat(2)1
Avg Revenue beat(2)2.08%
Min Revenue beat(2)-0.11%
Max Revenue beat(2)4.27%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-0.11%
Max Revenue beat(4)4.27%
Revenue beat(8)7
Avg Revenue beat(8)1.62%
Revenue beat(12)10
Avg Revenue beat(12)2.01%
Revenue beat(16)11
Avg Revenue beat(16)0.91%
PT rev (1m)7.56%
PT rev (3m)10.78%
EPS NQ rev (1m)0%
EPS NQ rev (3m)10.79%
EPS NY rev (1m)6.2%
EPS NY rev (3m)62.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.22%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)0.6%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 205.03 | ||
| Fwd PE | 86.74 | ||
| P/S | 2.98 | ||
| P/FCF | 74.69 | ||
| P/OCF | 21.69 | ||
| P/B | 6.09 | ||
| P/tB | 63.28 | ||
| EV/EBITDA | 30.96 |
EPS(TTM)0.36
EY0.49%
EPS(NY)0.85
Fwd EY1.15%
FCF(TTM)0.99
FCFY1.34%
OCF(TTM)3.4
OCFY4.61%
SpS24.8
BVpS12.12
TBVpS1.17
PEG (NY)N/A
PEG (5Y)12.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.42% | ||
| ROE | -1.6% | ||
| ROCE | 2.68% | ||
| ROIC | 2.21% | ||
| ROICexc | 3.07% | ||
| ROICexgc | 5.07% | ||
| OM | 4.17% | ||
| PM (TTM) | N/A | ||
| GM | 22.67% | ||
| FCFM | 3.98% |
ROA(3y)0.21%
ROA(5y)0.2%
ROE(3y)1.34%
ROE(5y)1.17%
ROIC(3y)2.96%
ROIC(5y)2.94%
ROICexc(3y)3.61%
ROICexc(5y)3.42%
ROICexgc(3y)6.03%
ROICexgc(5y)5.63%
ROCE(3y)3.6%
ROCE(5y)3.56%
ROICexcg growth 3Y-3.51%
ROICexcg growth 5Y-1.27%
ROICexc growth 3Y-4.28%
ROICexc growth 5Y-1.4%
OM growth 3Y-5.61%
OM growth 5Y-1.02%
PM growth 3Y-56.68%
PM growth 5Y-34.67%
GM growth 3Y0.24%
GM growth 5Y1.23%
F-Score4
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.16 | ||
| Debt/FCF | 14.51 | ||
| Debt/EBITDA | 5.61 | ||
| Cap/Depr | 165.16% | ||
| Cap/Sales | 9.74% | ||
| Interest Coverage | 0.93 | ||
| Cash Conversion | 136.29% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2 | ||
| Quick Ratio | 2 | ||
| Altman-Z | 2.08 |
F-Score4
WACC9%
ROIC/WACC0.25
Cap/Depr(3y)125.7%
Cap/Depr(5y)126.7%
Cap/Sales(3y)9.85%
Cap/Sales(5y)9.84%
Profit Quality(3y)1105%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.84%
EPS 3Y-1.04%
EPS 5Y16.79%
EPS Q2Q%93.75%
EPS Next Y-39.08%
EPS Next 2Y16.22%
EPS Next 3Y26.32%
EPS Next 5YN/A
Revenue 1Y (TTM)11.32%
Revenue growth 3Y11.64%
Revenue growth 5Y9.65%
Sales Q2Q%8.38%
Revenue Next Year8.63%
Revenue Next 2Y8.59%
Revenue Next 3Y7.97%
Revenue Next 5YN/A
EBIT growth 1Y-27.98%
EBIT growth 3Y5.38%
EBIT growth 5Y8.53%
EBIT Next Year113.89%
EBIT Next 3Y40.5%
EBIT Next 5YN/A
FCF growth 1Y93.91%
FCF growth 3Y90.52%
FCF growth 5Y8.35%
OCF growth 1Y44.3%
OCF growth 3Y15.95%
OCF growth 5Y17.44%